These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25261416)

  • 21. Characterisation of novel mutations involved in quinolone resistance in Escherichia coli isolated from imported shrimp.
    Nawaz M; Sung K; Kweon O; Khan S; Nawaz S; Steele R
    Int J Antimicrob Agents; 2015 May; 45(5):471-6. PubMed ID: 25631675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.
    Pong A; Thomson KS; Moland ES; Chartrand SA; Sanders CC
    J Antimicrob Chemother; 1999 Nov; 44(5):621-7. PubMed ID: 10552978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiological profile of ozenoxacin.
    Morrissey I; Cantón R; Vila J; Gargallo-Viola D; Zsolt I; Garcia-Castillo M; López Y
    Future Microbiol; 2019 Jun; 14():773-787. PubMed ID: 31132895
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro activity of Ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria.
    López Y; Tato M; Espinal P; Garcia-Alonso F; Gargallo-Viola D; Cantón R; Vila J
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6389-92. PubMed ID: 24080666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
    Okumura R; Hirata T; Onodera Y; Hoshino K; Otani T; Yamamoto T
    J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro susceptibility of recent gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin.
    Isenberg HD; Alperstein P; France K
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):115-8. PubMed ID: 9823535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
    Noviello S; Ianniello F; Leone S; Esposito S
    Infez Med; 2006 Mar; 14(1):24-8. PubMed ID: 17405239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci.
    Jones RN; Pfaller MA; Stilwell M;
    Diagn Microbiol Infect Dis; 2001 Feb; 39(2):133-5. PubMed ID: 11248528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of drug sensitivity and genotypes of clinically isolated strains of levofloxacin-resistant Streptococcus pneumoniae obtained from Okinawa Island, the Japanese main island and Hong Kong.
    Sunagawa S; Fujita J; Higa F; Tateyama M; Haranaga S; Nakasone I; Yamane N; Uno T
    J Antibiot (Tokyo); 2011 Aug; 64(8):539-45. PubMed ID: 21587266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
    Levy DD; Sharma B; Cebula TA
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2355-63. PubMed ID: 15215081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of quinolone resistance in Aeromonas species isolated from humans, water and eels.
    Alcaide E; Blasco MD; Esteve C
    Res Microbiol; 2010; 161(1):40-5. PubMed ID: 19900538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical Ozenoxacin Cream 1% for Impetigo: A Review.
    Schachner L; Andriessen A; Bhatia N; Grada A; Patele D
    J Drugs Dermatol; 2019 Jul; 18(7):655-661. PubMed ID: 31334625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.
    Wickman PA; Black JA; Moland ES; Thomson KS
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2255-7. PubMed ID: 16723599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ; Toleman MA; Walsh TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Jun; 55(2):119-27. PubMed ID: 16530373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
    Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis of type II topoisomerases of Aeromonas hydrophila isolated from fish and levofloxacin-induced resistant isolates in vitro.
    Hu R; Du N; Chen N; Lin L; Zhai Y; Gu Z
    Folia Microbiol (Praha); 2016 May; 61(3):249-53. PubMed ID: 26503714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis.
    Shultz TR; White PA; Tapsall JW
    Antimicrob Agents Chemother; 2005 May; 49(5):1753-60. PubMed ID: 15855492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008.
    Yang H; Duan G; Zhu J; Zhang W; Xi Y; Fan Q
    Int J Antimicrob Agents; 2013 Aug; 42(2):173-7. PubMed ID: 23796894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
    Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of quinolone resistance-determining region mutations and efflux pump expression in Neisseria meningitidis resistant to fluoroquinolones.
    Castanheira M; Deshpande LM; Jones RN; Farrell DJ
    Diagn Microbiol Infect Dis; 2012 Mar; 72(3):263-6. PubMed ID: 22321998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.